RAUL TELLEZ RODRIGUEZ: Open Payments
NPI 1679307797 · MADERA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,632 in 158 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $347 · 2025 $3,632
Food & beverage: $3,547Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $713 |
| Madrigal Pharmaceuticals | 19 | $629 |
| Janssen Biotech, Inc. | 13 | $497 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $381 |
| Gilead Sciences, Inc. | 5 | $333 |
| Aimmune Therapeutics, Inc. | 21 | $256 |
| Ardelyx, Inc. | 20 | $235 |
| Regeneron Healthcare Solutions, Inc. | 7 | $184 |
| GENZYME CORPORATION | 1 | $125 |
| Ipsen Biopharmaceuticals, Inc | 4 | $111 |
Products named: REZDIFFRA, TREMFYA, XIFAXAN, DUPIXENT, LINZESS, IBSRELA, VOWST, RINVOQ.
Industry payments across CA — which companies pay providers there.
